Search

Tandem Diabetes Care Inc

Fermé

SecteurSoins de santé

17.17 0.23

Résumé

Variation du prix de l'action

24h

Actuel

Min

16.95

Max

17.25

Chiffres clés

By Trading Economics

Revenu

-20M

-20M

Ventes

-43M

247M

BPA

-0.3

Marge bénéficiaire

-8.249

Employés

2,500

EBITDA

-25M

-14M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+68.75% upside

Dividendes

By Acuity

Prochains Résultats

6 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-121M

1.2B

Ouverture précédente

16.94

Clôture précédente

17.17

Sentiment de l'Actualité

By Acuity

50%

50%

146 / 340 Classement par Healthcare

Tandem Diabetes Care Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 juil. 2026, 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21 juil. 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20 juil. 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Comparaison

Variation de prix

Tandem Diabetes Care Inc prévision

Objectif de Prix

By TipRanks

68.75% hausse

Prévisions sur 12 Mois

Moyen 28.89 USD  68.75%

Haut 55 USD

Bas 15.5 USD

Basé sur 15 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

15 ratings

9

Achat

6

Maintien

0

Vente

Sentiment

By Acuity

146 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
help-icon Live chat